ENvue Medical (FEED) Cash from Investing Activities (2014 - 2026)
ENvue Medical's (FEED) quarterly Cash from Investing Activities came in at -$17000.0 in Q1 2026, down 111.89% year-on-year from $143000.0 in Q1 2025, and up 26.09% on a QoQ basis from -$23000.0 in Q4 2025.
ENvue Medical (FEED) Cash from Investing Activities (2014 - 2026) Analysis & Trends
ENvue Medical (FEED) has 11 years of Cash from Investing Activities data on file, last reported at -$17000.0 in Q1 2026.
- On a quarterly basis, Cash from Investing Activities fell 111.89% year-over-year to -$17000.0 in Q1 2026; TTM through Mar 2026 was -$72000.0, a 151.06% decrease from a year earlier, with the FY2025 full-year figure at $88000.0, up 3033.33% from the prior year.
- Cash from Investing Activities for Q1 2026 stood at -$17000.0, up from -$23000.0 in the prior quarter.
- Over the last five years, Cash from Investing Activities for FEED reached as high as $143000.0 in Q1 2025 and fell as low as -$28000.0 in Q3 2025.
- Historically, Cash from Investing Activities has averaged $6600.0 across 5 years, with a median of -$2000.0 in 2022.
- Across the five-year window, Cash from Investing Activities soared 14400.0% in 2025 and tumbled 111.89% in 2026, its largest moves.
- Year by year, Cash from Investing Activities stood at $1000.0 in 2022, then slumped by 200.0% to -$1000.0 in 2023, then sank by 100.0% to -$2000.0 in 2024, then plunged by 1050.0% to -$23000.0 in 2025, then advanced by 26.09% to -$17000.0 in 2026.
- Per Business Quant data, the three most recent Cash from Investing Activities figures were -$17000.0 in Q1 2026, -$23000.0 in Q4 2025, and -$28000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.32 Bn | 175.02 Bn | 6.27 Bn | -20.32 Bn |
| 2 | Stryker | 128.75 Bn | 125.88 Bn | 3.81 Bn | -185.00 Mn |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn | -917.00 Mn |
| 4 | Boston Scientific | 67.61 Bn | 66.15 Bn | 3.61 Bn | -591.00 Mn |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.45 Bn | 1.29 Bn | -92.80 Mn |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn | -298.50 Mn |
| 7 | GE HealthCare Technologies | 27.78 Bn | 25.50 Bn | 1.98 Bn | -2.50 Bn |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - | - |
| 9 | Koninklijke Philips | 23.92 Bn | 20.80 Bn | 2.07 Bn | -475.32 Mn |
| 10 | ENvue Medical | 1.18 Mn | -1.09 Mn | -55,000.00 | -17,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -17,000.00 |
| Mar 31, 2026 | -17,000.00 |
| Dec 31, 2025 | -23,000.00 |
| Dec 31, 2025 | -23,000.00 |
| Sep 30, 2025 | -28,000.00 |
| Sep 30, 2025 | -28,000.00 |
| Jun 30, 2025 | -4,000.00 |
| Jun 30, 2025 | -4,000.00 |
| Mar 31, 2025 | 143,000.00 |
| Mar 31, 2025 | 143,000.00 |
| Jun 30, 2024 | -2,000.00 |
| Jun 30, 2024 | -2,000.00 |
| Mar 31, 2024 | -1,000.00 |
| Mar 31, 2024 | -1,000.00 |
| Mar 31, 2023 | -1,000.00 |
| Mar 31, 2023 | -1,000.00 |
| Dec 31, 2022 | 1,000.00 |
| Dec 31, 2022 | 1,000.00 |
| Sep 30, 2022 | -2,000.00 |
| Sep 30, 2022 | -2,000.00 |